GOLD MITCHELL

CIK 00012428823 companiesSAN CARLOS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001242882

Recent Transactions

50 trades

Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−70,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−215,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−247,951→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−208,916→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−240,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−96,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−336,755→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−270,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−200,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−13,245→ 96,000 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−255,000→ 0 total
Disposition from Tender
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-18−2,627,157→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-08$7.55/sh+13,245→ 109,245 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-08−13,245→ 336,755 total
Award
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-04+96,000→ 96,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-04+240,000→ 240,000 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$20.04/sh−1,016→ 0 total
Tax Payment
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$19.65/sh−48,264→ 2,627,157 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Warrant (right to buy)
2023-12-28−74,441→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$12.74/sh+74,441→ 2,675,421 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-28−1,016→ 247,951 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$0.65/sh+1,016→ 1,016 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-27$20.04/sh−29,573→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-27−29,573→ 248,967 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-27$0.65/sh+29,573→ 29,573 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-26$0.65/sh+22,084→ 24,486 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-26−22,084→ 278,540 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-26$20.22/sh−24,486→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-26−2,402→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-26$0.45/sh+2,402→ 2,402 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-22$20.43/sh−37,825→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-22−37,825→ 2,402 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-22$0.45/sh+37,825→ 37,825 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-19−2,402→ 40,227 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-19$20.01/sh−2,402→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-19$0.45/sh+2,402→ 2,402 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-12$0.45/sh+8,613→ 8,613 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-12$17.32/sh−32,450→ 0 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-12$17.32/sh−8,613→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-12−8,613→ 42,629 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-11$17.26/sh−68,870→ 32,450 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-08$17.08/sh−8,067→ 101,320 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-01-04+350,000→ 350,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2022-01-04+215,000→ 215,000 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-09-17$10.01/sh−45,262→ 109,387 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-09-17$9.40/sh−400,000→ 2,600,980 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-09-16$10.00/sh−6,768→ 154,649 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-09-15$10.00/sh−3,484→ 161,417 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-06-28$10.00/sh−3,479→ 164,901 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-06-25$10.01/sh−9,473→ 168,380 total

Companies

Recent Filings

Address

C/O ATTOVIA THERAPEUTICS, INC. 1091 INDUSTRIAL ROAD, SUITE 310

SAN CARLOS, CA, 94070

View on SEC.gov